Reactions Weekly

, Volume 1694, Issue 1, pp 13–13 | Cite as

PDE5 inhibitors associated with sensorineural hearing loss

Clinical study


  1. Liu W, et al. Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study. Pharmacoepidemiology and Drug Safety : 7 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations